This post was written by Naomi Buchanan. As US stock continue their rate cut-fueled rally, Evercore ISI senior managing director of equity, derivatives, and quantitative strategy Julian Emanuel, joins ...

If the current McDonald's x Crocs Happy Meal collaboration has you thinking about getting a pair to wear, those are available ...

Over the past 12 months, the stock has posted gains in 9 months, with January leading the way with a 27% increase, followed ...

Shares of Donald Trump's media company fell for a second session on Tuesday ahead of the end of restrictions on share sales ...

Fans are super excited for Squid Game Season 2, with Netflix unveiling a brand-new trailer and poster during its Geeked Week ...

Analysts have recently evaluated Rhythm Pharmaceuticals and provided 12-month price targets. The average target is $59.5, ...

Pathways Support ($65): Pathways Support was meticulously crafted to enhance metabolic function, boost thiamine, reduce harmful bacteria and improve gamma-aminobutyric acid (GABA) levels – a calming ...

Stocks on Sweden's OMX Stockholm 30 Index gained 1.9%, and Norway's Oslo Exchange Benchmark Index_GI gained 0.8%. Shares in Iceland increased, with the OMX Iceland All-Share PI Equity Index adding 0.9 ...

Gilead’s twice-yearly injection for HIV prevention cut infections by 96% in a late-stage trial, the company said Thursday, ...

Monday's Apple iPhone 16 unveiling is key for AI and a reeling stock market. Palantir and Dell will be joining the S&P 500. Elon Musk's xAI has discussed sharing Tesla FSD revenue. SYDNEY (Reuters) ...

In a report released yesterday, Justin Zelin from BTIG maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), with a ...

Monday's Apple iPhone 16 unveiling is key for AI and a reeling stock market. Palantir and Dell will be joining the S&P 500. Elon Musk's xAI has discussed sharing Tesla FSD revenue. SYDNEY (Reuters) ...